v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Preferred stock
Series A Preferred Stock
Preferred stock
Series T Preferred Stock
Preferred stock
Series Seed Preferred Stock
Common Stock
Additional Paid-in Capital
Noncontrolling Interest
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2024 $ 5,286,667 $ 983,634 $ 1,706,756 $ 7,028 $ 95,543,998 $ (13,251) $ (61,174,088) $ 42,340,744
Balance at the beginning (in shares) at Dec. 31, 2024 185,440,880 9,642,080 204,810,720 702,861,520        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Sale of common Stock       $ 19 2,125,007     2,125,026
Sale of Common Stock (in shares)       1,922,194        
Offering Costs         (1,444,755)     (1,444,755)
Stock compensation expense         2,651,080     2,651,080
Net Income (Loss)             1,717,451 1,717,451
Balance at the end at Mar. 31, 2025 $ 5,286,667 $ 983,634 $ 1,706,756 $ 7,047 98,875,330 (13,251) (59,456,637) 47,389,546
Balance at the end (in shares) at Mar. 31, 2025 185,440,880 9,642,080 204,810,720 704,783,714        
Balance at the beginning at Dec. 31, 2024 $ 5,286,667 $ 983,634 $ 1,706,756 $ 7,028 95,543,998 (13,251) (61,174,088) $ 42,340,744
Balance at the beginning (in shares) at Dec. 31, 2024 185,440,880 9,642,080 204,810,720 702,861,520        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Sale of Common Stock (in shares)               9,347,504
Offering Costs               $ (6,006,272)
Net Income (Loss)               6,156,411
Balance at the end at Sep. 30, 2025 $ 5,286,667 $ 983,634 $ 1,706,441 $ 7,429 106,873,654 (13,251) (55,017,677) 59,826,897
Balance at the end (in shares) at Sep. 30, 2025 185,440,880 9,642,080 204,772,940 743,042,911        
Balance at the beginning at Mar. 31, 2025 $ 5,286,667 $ 983,634 $ 1,706,756 $ 7,047 98,875,330 (13,251) (59,456,637) 47,389,546
Balance at the beginning (in shares) at Mar. 31, 2025 185,440,880 9,642,080 204,810,720 704,783,714        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Sale of common Stock       $ 57 6,305,843     6,305,900
Sale of Common Stock (in shares)       5,741,843        
Exercise of stock options       $ 182 105,852     106,034
Exercise of stock options (in shares)       18,242,157        
Offering Costs         (4,139,770)     (4,139,770)
Stock compensation expense         2,526,438     2,526,438
Net Income (Loss)             3,277,901 3,277,901
Balance at the end at Jun. 30, 2025 $ 5,286,667 $ 983,634 $ 1,706,756 $ 7,286 103,673,693 (13,251) (56,178,736) 55,466,049
Balance at the end (in shares) at Jun. 30, 2025 185,440,880 9,642,080 204,810,720 728,767,714        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Sale of common Stock       $ 17 1,895,048     1,895,065
Sale of Common Stock (in shares)       1,683,467        
Conversion of Preferred Stock     $ (315)   315      
Conversion of Preferred Stock (in shares)     (37,780) 37,780        
Exercise of stock options       $ 126 473,927     474,053
Exercise of stock options (in shares)       12,553,950        
Offering Costs         (421,747)     (421,747)
Stock compensation expense         1,252,418     1,252,418
Net Income (Loss)             1,161,059 1,161,059
Balance at the end at Sep. 30, 2025 $ 5,286,667 $ 983,634 $ 1,706,441 $ 7,429 106,873,654 (13,251) (55,017,677) 59,826,897
Balance at the end (in shares) at Sep. 30, 2025 185,440,880 9,642,080 204,772,940 743,042,911        
Balance at the beginning at Dec. 31, 2025 $ 5,286,667 $ 983,634 $ 1,706,441 $ 7,457 108,376,818 (13,251) (59,701,236) 56,646,530
Balance at the beginning (in shares) at Dec. 31, 2025 185,440,880 9,642,080 204,772,940 745,825,392        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Sale of common Stock       $ 37 5,117,792     5,117,829
Sale of Common Stock (in shares)       3,653,075        
Vinovest acquisition       $ 88 13,999,912     14,000,000
Vinovest acquisition (in shares)       8,750,000        
Exercise of stock options         8,250     8,250
Exercise of stock options (in shares)       38,077        
Offering Costs         (4,101,971)     (4,101,971)
Stock compensation expense         2,838,266     2,838,266
Net Income (Loss)             (2,234,904) (2,234,904)
Balance at the end at Mar. 31, 2026 $ 5,286,667 $ 983,634 $ 1,706,441 $ 7,582 126,239,067 (13,251) (61,936,140) 72,274,000
Balance at the end (in shares) at Mar. 31, 2026 185,440,880 9,642,080 204,772,940 758,266,544        
Balance at the beginning at Dec. 31, 2025 $ 5,286,667 $ 983,634 $ 1,706,441 $ 7,457 108,376,818 (13,251) (59,701,236) $ 56,646,530
Balance at the beginning (in shares) at Dec. 31, 2025 185,440,880 9,642,080 204,772,940 745,825,392        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Sale of Common Stock (in shares)               3,726,152
Offering Costs               $ (4,101,971)
Net Income (Loss)               (3,543,612)
Balance at the end at Sep. 30, 2026 $ 5,286,667 $ 983,634 $ 1,706,441 $ 7,591 131,120,243 (13,251) (63,244,848) 75,846,477
Balance at the end (in shares) at Sep. 30, 2026 185,440,880 9,642,080 204,772,940 758,436,454        
Balance at the beginning at Mar. 31, 2026 $ 5,286,667 $ 983,634 $ 1,706,441 $ 7,582 126,239,067 (13,251) (61,936,140) 72,274,000
Balance at the beginning (in shares) at Mar. 31, 2026 185,440,880 9,642,080 204,772,940 758,266,544        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Sale of common Stock       $ 7 96,733     96,740
Sale of Common Stock (in shares)       73,077        
Exercise of stock options       $ 1 6,749     6,750
Exercise of stock options (in shares)       10,000        
Stock compensation expense         2,339,194     2,339,194
Net Income (Loss)             1,827,274 1,827,274
Balance at the end at Jun. 30, 2026 $ 5,286,667 $ 983,634 $ 1,706,441 $ 7,590 128,681,743 (13,251) (60,108,866) 76,543,958
Balance at the end (in shares) at Jun. 30, 2026 185,440,880 9,642,080 204,772,940 758,349,621        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Sale of common Stock         120     $ 120
Sale of Common Stock (in shares)               0
Exercise of stock options       $ 1 12,396     $ 12,397
Exercise of stock options (in shares)       86,833        
Stock compensation expense         2,425,984     2,425,984
Net Income (Loss)             (3,135,982) (3,135,982)
Balance at the end at Sep. 30, 2026 $ 5,286,667 $ 983,634 $ 1,706,441 $ 7,591 $ 131,120,243 $ (13,251) $ (63,244,848) $ 75,846,477
Balance at the end (in shares) at Sep. 30, 2026 185,440,880 9,642,080 204,772,940 758,436,454